French life-sciences firm specialising in Enzymatic DNA Synthesis and DNA printing.
| Date | Round | Amount |
|---|---|---|
| Jan 2022 | Series C Paris DNA-synthesis firm DNA Script completed a 176.8M euro Series C to commercialise its SYNTAX enzymatic DNA-printing platform. | $176.8M |